Aethlon Medical, Inc. (AEMD)
USD 0.33
(-5.27%)
USD 0.33
(-5.27%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 8.24 Million USD | -52.9% |
| 2023 | 17.5 Million USD | -9.83% |
| 2022 | 19.41 Million USD | 82.0% |
| 2021 | 10.66 Million USD | 2.71% |
| 2020 | 10.38 Million USD | 151.95% |
| 2019 | 4.12 Million USD | -43.92% |
| 2018 | 7.35 Million USD | 325.86% |
| 2017 | 1.72 Million USD | -32.48% |
| 2016 | 2.55 Million USD | 85.19% |
| 2015 | 1.38 Million USD | -18.55% |
| 2014 | 1.69 Million USD | 241.28% |
| 2013 | 496.69 Thousand USD | -40.78% |
| 2012 | 838.69 Thousand USD | 47.86% |
| 2011 | 567.21 Thousand USD | -12.2% |
| 2010 | 646 Thousand USD | 227.27% |
| 2009 | 197.38 Thousand USD | -59.56% |
| 2008 | 488.1 Thousand USD | -20.42% |
| 2007 | 613.35 Thousand USD | -40.44% |
| 2006 | 1.02 Million USD | 242.86% |
| 2005 | 300.35 Thousand USD | 6.64% |
| 2004 | 281.66 Thousand USD | -29.32% |
| 2003 | 398.52 Thousand USD | -59.06% |
| 2002 | 973.53 Thousand USD | -24.18% |
| 2001 | 1.28 Million USD | -2.73% |
| 2000 | 1.32 Million USD | 1508.33% |
| 1999 | 82.07 Thousand USD | 10785.01% |
| 1998 | 754.00 USD | -72.32% |
| 1997 | 2724.00 USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 12.82 Million USD | -18.81% |
| 2024 Q4 | 8.24 Million USD | -20.99% |
| 2024 Q3 | 10.43 Million USD | -18.64% |
| 2024 FY | 8.24 Million USD | -52.9% |
| 2024 Q1 | 15.8 Million USD | -9.76% |
| 2023 Q2 | 23.04 Million USD | 34.53% |
| 2023 Q3 | 20.72 Million USD | -10.08% |
| 2023 FY | 17.5 Million USD | -9.83% |
| 2023 Q1 | 17.13 Million USD | -11.77% |
| 2023 Q4 | 17.5 Million USD | -15.52% |
| 2022 Q2 | 23.87 Million USD | -7.7% |
| 2022 Q1 | 25.86 Million USD | 142.45% |
| 2022 FY | 19.41 Million USD | 82.0% |
| 2022 Q4 | 19.41 Million USD | -11.4% |
| 2022 Q3 | 21.91 Million USD | -8.2% |
| 2021 Q2 | 15.05 Million USD | -8.35% |
| 2021 Q3 | 12.66 Million USD | -15.85% |
| 2021 Q4 | 10.66 Million USD | -15.79% |
| 2021 FY | 10.66 Million USD | 2.71% |
| 2021 Q1 | 16.42 Million USD | 58.14% |
| 2020 Q3 | 4.68 Million USD | 265.31% |
| 2020 Q4 | 10.38 Million USD | 121.84% |
| 2020 FY | 10.38 Million USD | 151.95% |
| 2020 Q1 | 2.93 Million USD | -28.86% |
| 2020 Q2 | 1.28 Million USD | -56.3% |
| 2019 FY | 4.12 Million USD | -43.92% |
| 2019 Q4 | 4.12 Million USD | -16.72% |
| 2019 Q1 | 6.45 Million USD | -12.22% |
| 2019 Q2 | 5.27 Million USD | -18.3% |
| 2019 Q3 | 4.95 Million USD | -6.1% |
| 2018 Q2 | 1.14 Million USD | 125.08% |
| 2018 Q4 | 7.35 Million USD | 27.84% |
| 2018 FY | 7.35 Million USD | 325.86% |
| 2018 Q1 | 509.15 Thousand USD | -70.51% |
| 2018 Q3 | 5.75 Million USD | 401.82% |
| 2017 Q2 | 950.83 Thousand USD | -34.92% |
| 2017 Q4 | 1.72 Million USD | 118.64% |
| 2017 FY | 1.72 Million USD | -32.48% |
| 2017 Q1 | 1.46 Million USD | -42.86% |
| 2017 Q3 | 789.59 Thousand USD | -16.96% |
| 2016 Q4 | 2.55 Million USD | -28.84% |
| 2016 FY | 2.55 Million USD | 85.19% |
| 2016 Q1 | 5.97 Million USD | 332.72% |
| 2016 Q2 | 4.7 Million USD | -21.23% |
| 2016 Q3 | 3.59 Million USD | -23.65% |
| 2015 Q3 | 3.15 Million USD | 189.78% |
| 2015 Q1 | 1.14 Million USD | -32.49% |
| 2015 FY | 1.38 Million USD | -18.55% |
| 2015 Q4 | 1.38 Million USD | -56.26% |
| 2015 Q2 | 1.08 Million USD | -4.82% |
| 2014 Q2 | 411.19 Thousand USD | 110.6% |
| 2014 Q1 | 195.24 Thousand USD | -60.69% |
| 2014 Q4 | 1.69 Million USD | -19.47% |
| 2014 FY | 1.69 Million USD | 241.28% |
| 2014 Q3 | 2.1 Million USD | 411.93% |
| 2013 Q3 | 307.06 Thousand USD | -35.32% |
| 2013 Q2 | 474.72 Thousand USD | -42.3% |
| 2013 Q1 | 822.77 Thousand USD | -1.9% |
| 2013 FY | 496.69 Thousand USD | -40.78% |
| 2013 Q4 | 496.69 Thousand USD | 61.76% |
| 2012 FY | 838.69 Thousand USD | 47.86% |
| 2012 Q1 | 322.07 Thousand USD | -43.22% |
| 2012 Q4 | 838.69 Thousand USD | -7.12% |
| 2012 Q2 | 323.12 Thousand USD | 0.33% |
| 2012 Q3 | 903.02 Thousand USD | 179.47% |
| 2011 Q1 | 741.2 Thousand USD | 14.74% |
| 2011 Q4 | 567.21 Thousand USD | -41.3% |
| 2011 Q3 | 966.3 Thousand USD | -32.83% |
| 2011 FY | 567.21 Thousand USD | -12.2% |
| 2011 Q2 | 1.43 Million USD | 94.08% |
| 2010 Q1 | 294.07 Thousand USD | 48.98% |
| 2010 FY | 646 Thousand USD | 227.27% |
| 2010 Q4 | 646 Thousand USD | 137.6% |
| 2010 Q3 | 271.88 Thousand USD | -10.06% |
| 2010 Q2 | 302.28 Thousand USD | 2.79% |
| 2009 Q4 | 197.38 Thousand USD | -43.28% |
| 2009 Q2 | 196.37 Thousand USD | -43.46% |
| 2009 FY | 197.38 Thousand USD | -59.56% |
| 2009 Q3 | 347.97 Thousand USD | 77.2% |
| 2009 Q1 | 347.33 Thousand USD | -28.84% |
| 2008 Q2 | 353.32 Thousand USD | 106.34% |
| 2008 Q4 | 488.1 Thousand USD | -12.27% |
| 2008 Q3 | 556.34 Thousand USD | 57.46% |
| 2008 FY | 488.1 Thousand USD | -20.42% |
| 2008 Q1 | 171.23 Thousand USD | -72.08% |
| 2007 Q1 | 597.84 Thousand USD | -41.94% |
| 2007 Q4 | 613.35 Thousand USD | 171.19% |
| 2007 Q3 | 226.17 Thousand USD | -8.69% |
| 2007 Q2 | 247.68 Thousand USD | -58.57% |
| 2007 FY | 613.35 Thousand USD | -40.44% |
| 2006 FY | 1.02 Million USD | 242.86% |
| 2006 Q1 | 290.96 Thousand USD | -3.13% |
| 2006 Q4 | 1.02 Million USD | 183.32% |
| 2006 Q2 | 347.73 Thousand USD | 19.51% |
| 2006 Q3 | 363.46 Thousand USD | 4.53% |
| 2005 Q3 | 366.03 Thousand USD | 17.65% |
| 2005 Q1 | 653.44 Thousand USD | 132.0% |
| 2005 FY | 300.35 Thousand USD | 6.64% |
| 2005 Q4 | 300.35 Thousand USD | -17.94% |
| 2005 Q2 | 311.12 Thousand USD | -52.39% |
| 2004 Q2 | 318.7 Thousand USD | 0.0% |
| 2004 FY | 281.66 Thousand USD | -29.32% |
| 2004 Q3 | 283.05 Thousand USD | -11.18% |
| 2004 Q4 | 281.66 Thousand USD | -0.49% |
| 2004 Q1 | 318.7 Thousand USD | -20.03% |
| 2003 Q3 | 783.51 Thousand USD | -11.39% |
| 2003 Q4 | 398.52 Thousand USD | -49.14% |
| 2003 Q2 | 884.25 Thousand USD | -0.34% |
| 2003 Q1 | 887.23 Thousand USD | -8.86% |
| 2003 FY | 398.52 Thousand USD | -59.06% |
| 2002 Q3 | 1.02 Million USD | -7.07% |
| 2002 Q1 | 1.34 Million USD | 4.84% |
| 2002 Q2 | 1.1 Million USD | -18.22% |
| 2002 FY | 973.53 Thousand USD | -24.18% |
| 2002 Q4 | 973.53 Thousand USD | -4.83% |
| 2001 FY | 1.28 Million USD | -2.73% |
| 2001 Q3 | 2.19 Million USD | -4.23% |
| 2001 Q4 | 1.28 Million USD | -41.48% |
| 2001 Q1 | 2.33 Million USD | 76.69% |
| 2001 Q2 | 2.29 Million USD | -1.78% |
| 2000 FY | 1.32 Million USD | 1508.33% |
| 2000 Q1 | 78.26 Thousand USD | 0.0% |
| 2000 Q2 | 116.04 Thousand USD | 48.28% |
| 2000 Q4 | 1.32 Million USD | 575.86% |
| 2000 Q3 | 195.3 Thousand USD | 68.3% |
| 1999 FY | 82.07 Thousand USD | 10785.01% |
| 1998 FY | 754.00 USD | -72.32% |
| 1997 FY | 2724.00 USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | 73.71% |
| BrainsWay Ltd. | 62.97 Million USD | 86.905% |
| Cerus Corporation | 197.74 Million USD | 95.83% |
| Envoy Medical, Inc. | 7.64 Million USD | -7.932% |
| electroCore, Inc. | 16.38 Million USD | 49.68% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -7.202% |
| IceCure Medical Ltd | 16.41 Million USD | 49.75% |
| Inogen, Inc. | 326.19 Million USD | 97.472% |
| OrthoPediatrics Corp. | 449.58 Million USD | 98.166% |
| Lucid Diagnostics Inc. | 27.27 Million USD | 69.762% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | 50.263% |
| MaxCyte, Inc. | 268.27 Million USD | 96.926% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -1.836% |
| Nexalin Technology, Inc. | 3.63 Million USD | -127.042% |
| Orthofix Medical Inc. | 925.31 Million USD | 99.109% |
| PAVmed Inc | 33.11 Million USD | 75.102% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 94.252% |
| RxSight, Inc. | 182.55 Million USD | 95.483% |
| Sight Sciences, Inc. | 166.65 Million USD | 95.052% |
| SI-BONE, Inc. | 230.42 Million USD | 96.421% |
| TELA Bio, Inc. | 78.04 Million USD | 89.435% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 96.727% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | 23.15% |
| Acutus Medical, Inc. | 53.96 Million USD | 84.718% |
| Talis Biomedical Corporation | 98.34 Million USD | 91.615% |
| Spectral AI, Inc. | 10.69 Million USD | 22.877% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 96.229% |
| CVRx, Inc. | 115.22 Million USD | 92.844% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 85.943% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -164.697% |
| Bioventus Inc. | 810.91 Million USD | 98.983% |
| Venus Concept Inc. | 93.65 Million USD | 91.195% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | 67.946% |
| LivaNova PLC | 2.42 Billion USD | 99.661% |
| 908 Devices Inc. | 202.98 Million USD | 95.938% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 98.976% |
| Nemaura Medical Inc. | 14.56 Million USD | 43.378% |
| NeuroPace, Inc. | 107.65 Million USD | 92.34% |
| LENSAR, Inc. | 69.58 Million USD | 88.15% |
| Apyx Medical Corporation | 79.24 Million USD | 89.594% |
| Cutera, Inc. | 346.29 Million USD | 97.619% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 80.374% |
| BioSig Technologies, Inc. | 1.79 Million USD | -358.62% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 96.953% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 80.671% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.782% |
| Axonics, Inc. | 719.92 Million USD | 98.855% |
| Outset Medical, Inc. | 313.8 Million USD | 97.372% |
| IRIDEX Corporation | 34.43 Million USD | 76.054% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 97.963% |
| IRadimed Corporation | 92.15 Million USD | 91.052% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -56.947% |
| INVO Bioscience, Inc. | 20.88 Million USD | 60.522% |
| Telesis Bio, Inc. | 70.41 Million USD | 88.289% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 94.649% |
| Varex Imaging Corporation | 1.24 Billion USD | 99.34% |
| Quipt Home Medical Corp. | 247.4 Million USD | 96.667% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 11.429% |
| Pulmonx Corporation | 178.95 Million USD | 95.392% |
| Dynatronics Corporation | 25.94 Million USD | 68.212% |
| Modular Medical, Inc. | 13.8 Million USD | 40.277% |
| ReShape Lifesciences Inc. | 10.72 Million USD | 23.129% |
| Semler Scientific, Inc. | 78.06 Million USD | 89.437% |
| InMode Ltd. | 863.28 Million USD | 99.045% |
| Bruker Corporation | 4.24 Billion USD | 99.806% |
| Cytosorbents Corporation | 53.26 Million USD | 84.518% |
| DexCom, Inc. | 6.26 Billion USD | 99.868% |
| Align Technology, Inc. | 6.08 Billion USD | 99.864% |
| Viveve Medical, Inc. | 25.91 Million USD | 68.178% |
| ZimVie Inc. | 1.2 Billion USD | 99.316% |
| Movano Inc. | 9.42 Million USD | 12.472% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 98.343% |
| Nexalin Technology, Inc. | 3.63 Million USD | -127.042% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 85.943% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 99.134% |
| Profound Medical Corp. | 43.68 Million USD | 81.125% |
| Insulet Corporation | 2.58 Billion USD | 99.681% |
| enVVeno Medical Corporation | 48.63 Million USD | 83.045% |
| Surmodics, Inc. | 185.73 Million USD | 95.56% |
| iCAD, Inc. | 41.41 Million USD | 80.091% |
| Nuwellis, Inc. | 9.77 Million USD | 15.599% |
| Biotricity, Inc. | 5.94 Million USD | -38.76% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 98.096% |
| InspireMD, Inc. | 47.64 Million USD | 82.692% |
| PAVmed Inc. | 33.11 Million USD | 75.102% |
| BIOLASE, Inc. | 35.1 Million USD | 76.508% |
| Beyond Air, Inc. | 56.96 Million USD | 85.523% |
| FONAR Corporation | 214.24 Million USD | 96.151% |
| AxoGen, Inc. | 196.82 Million USD | 95.811% |
| Vivani Medical, Inc. | 45.79 Million USD | 81.994% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 97.07% |
| Inari Medical, Inc. | 674.23 Million USD | 98.777% |
| UFP Technologies, Inc. | 404.13 Million USD | 97.96% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | 64.759% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | 13.229% |
| Tenon Medical, Inc. | 6.34 Million USD | -29.96% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | 12.342% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 92.044% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.822% |
| Sintx Technologies, Inc. | 15.36 Million USD | 46.333% |
| NanoVibronix, Inc. | 6.67 Million USD | -23.554% |
| Quanterix Corporation | 425.01 Million USD | 98.06% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | 11.429% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 84.652% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 99.528% |
| TransMedics Group, Inc. | 706.04 Million USD | 98.832% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 86.951% |
| NeuroMetrix, Inc. | 21.42 Million USD | 61.511% |
| Hyperfine, Inc. | 94.19 Million USD | 91.246% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 96.93% |
| Biomerica, Inc. | 9.25 Million USD | 10.893% |
| Bone Biologics Corporation | 3.73 Million USD | -120.613% |
| AVITA Medical, Inc. | 144.33 Million USD | 94.287% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -69.373% |
| Silk Road Medical, Inc | 265.3 Million USD | 96.892% |